Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
IPO Year: 1992
Exchange: NYSE
Website: omegahealthcare.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/27/2025 | $41.00 → $39.00 | Overweight → Equal Weight | Wells Fargo |
| 12/9/2024 | $45.00 | Market Perform → Outperform | BMO Capital Markets |
| 10/31/2024 | $49.00 | Neutral → Outperform | Exane BNP Paribas |
| 10/18/2024 | $45.00 | Buy | Berenberg |
| 7/25/2024 | $34.00 → $35.00 | Outperform → Neutral | Mizuho |
| 3/22/2024 | $32.00 → $35.00 | Neutral → Buy | Citigroup |
| 2/26/2024 | $31.00 → $35.00 | Equal Weight → Overweight | Wells Fargo |
| 2/8/2024 | $30.00 | Underperform → Neutral | Exane BNP Paribas |
| 1/30/2024 | $36.00 | Buy | Deutsche Bank |
| 1/16/2024 | $33.00 → $31.00 | Buy → Neutral | BofA Securities |
Wells Fargo downgraded Omega Health from Overweight to Equal Weight and set a new price target of $39.00 from $41.00 previously
BMO Capital Markets upgraded Omega Health from Market Perform to Outperform and set a new price target of $45.00
Exane BNP Paribas upgraded Omega Health from Neutral to Outperform and set a new price target of $49.00
Berenberg initiated coverage of Omega Health with a rating of Buy and set a new price target of $45.00
Mizuho downgraded Omega Health from Outperform to Neutral and set a new price target of $35.00 from $34.00 previously
Citigroup upgraded Omega Health from Neutral to Buy and set a new price target of $35.00 from $32.00 previously
Wells Fargo upgraded Omega Health from Equal Weight to Overweight and set a new price target of $35.00 from $31.00 previously
Exane BNP Paribas upgraded Omega Health from Underperform to Neutral and set a new price target of $30.00
Deutsche Bank initiated coverage of Omega Health with a rating of Buy and set a new price target of $36.00
BofA Securities downgraded Omega Health from Buy to Neutral and set a new price target of $31.00 from $33.00 previously